Skip to main content
. 2015 Dec 15;7(4):4806–4816. doi: 10.18632/oncotarget.6624

Figure 3. Frequency of antiangiomiRs expression (miR-16, miR-20b, miR-92a, miR-221 and miR-328) in 84 samples of DLBCL.

Figure 3